Joshua Jennings

Stock Analyst at TD Cowen

(3.30)
# 987
Out of 5,182 analysts
82
Total ratings
47.44%
Success rate
4.03%
Average return

Stocks Rated by Joshua Jennings

Humacyte
Mar 30, 2026
Maintains: Buy
Price Target: $3.5$1
Current: $0.81
Upside: +24.08%
Butterfly Network
Feb 27, 2026
Maintains: Buy
Price Target: $4.5$6
Current: $5.48
Upside: +9.49%
PROCEPT BioRobotics
Feb 26, 2026
Maintains: Buy
Price Target: $50$34
Current: $24.09
Upside: +41.14%
Boston Scientific
Feb 5, 2026
Maintains: Buy
Price Target: $115$100
Current: $59.95
Upside: +66.81%
Johnson & Johnson
Jan 22, 2026
Maintains: Buy
Price Target: $222$250
Current: $225.34
Upside: +10.94%
Edwards Lifesciences
Jan 9, 2026
Upgrades: Buy
Price Target: $90$97
Current: $83.46
Upside: +16.22%
Orchestra BioMed Holdings
Dec 10, 2025
Initiates: Buy
Price Target: $15
Current: $4.10
Upside: +265.85%
CeriBell
Nov 5, 2025
Maintains: Buy
Price Target: $36$20
Current: $21.14
Upside: -5.39%
Senseonics Holdings
Nov 5, 2025
Maintains: Buy
Price Target: $25$15
Current: $7.27
Upside: +106.33%
DexCom
Oct 31, 2025
Maintains: Buy
Price Target: $100$84
Current: $61.41
Upside: +36.79%
Initiates: Buy
Price Target: $15
Current: $5.66
Upside: +165.02%
Maintains: Buy
Price Target: $264$324
Current: $188.31
Upside: +72.06%
Maintains: Buy
Price Target: $175$120
Current: $108.12
Upside: +10.99%
Maintains: Hold
Price Target: $143$119
Current: $92.59
Upside: +28.52%
Maintains: Buy
Price Target: $55$60
Current: $36.98
Upside: +62.25%
Maintains: Hold
Price Target: $83$80
Current: $74.13
Upside: +7.92%
Maintains: Buy
Price Target: $135$45
Current: $4.40
Upside: +923.89%
Downgrades: Hold
Price Target: $40
Current: $18.49
Upside: +116.33%
Maintains: Buy
Price Target: $365$400
Current: $329.01
Upside: +21.58%
Maintains: Outperform
Price Target: $50$60
Current: $65.47
Upside: -8.35%
Maintains: Outperform
Price Target: $52$34
Current: $19.82
Upside: +71.54%
Maintains: Outperform
Price Target: $14$18
Current: $6.79
Upside: +165.19%
Maintains: Outperform
Price Target: $6$25
Current: $16.57
Upside: +50.88%
Maintains: Outperform
Price Target: $130
Current: $92.80
Upside: +40.09%
Maintains: Outperform
Price Target: $7$5
Current: $1.93
Upside: +159.07%
Maintains: Outperform
Price Target: $125$117
Current: $82.92
Upside: +41.10%
Initiates: Outperform
Price Target: $12
Current: $10.36
Upside: +15.83%
Downgrades: Market Perform
Price Target: $306$275
Current: $150.22
Upside: +83.06%
Downgrades: Market Perform
Price Target: $28$28
Current: $9.94
Upside: +176.66%